World
Report now includes Scope 3 emissions Employee-driven social responsibility takes precedence as driving force for sustainability activities&...
June 14, 2023 | News
NewVale Capital leads $14 Million Series B growth round Industry leading executive, Rick Riegel, joins as Chairman of the Board Newly formed Strategic ...
June 14, 2023 | News
This study will be conducted at multiple clinical research centers including Sarah Cannon Research Institute (Florida Cancer Specialists & Research Ins...
June 13, 2023 | News
Oxford Nanopore Technologies plc (Oxford Nanopore), the company delivering a new generation of nanopore-based molecular sensing technology, and Geneyx, an ...
June 12, 2023 | News
BioPharma APAC in an interaction with Tomas Blomquist, CEO and President of Biotage, to gain insights into the recent acquisition of Astrea Biosepara...
June 07, 2023 | News
Proteologix to receive in-kind products and services to develop treatments for autoimmune/inflammatory diseases and oncology indications Experts from Me...
June 07, 2023 | News
Integration of Sartorius' process scale multi-column chromatography with Waters' process analytical technology to provide robust analytical data ...
June 06, 2023 | News
Biotage has completed the acquisition of Astrea Bioseparations, a high-growth chromatography solutions provider from Gamma Biosciences, a life sciences too...
June 02, 2023 | News
Agilent Technologies Inc. (NYSE: A) announces the 10th anniversary of the Agilent BioTek Cytation 3 cell imaging multimode reader and the Agilen...
June 01, 2023 | News
"The initiation of our FIH study with JCXH-105 is an important milestone for Immorna and for the development of a potential innovative vaccine for Shingles...
May 31, 2023 | News
ORSERDU (elacestrant) was approved by the FDA in January 2023 for advanced or metastatic estrogen receptor (ER)-positive, human epidermal growth factor (...
May 30, 2023 | News
Under an exclusive licensing agreement, Amplo Biotechnology has gained access to AAV-ColQ data developed by Professor Kinji Ohno's laboratory at&...
May 30, 2023 | News
If approved, Opdivo with chemotherapy would be the first and only neoadjuvant immunotherapy-based option authorized to treat patients with non-sm...
May 29, 2023 | Regulatory
Life Edit has the option to a global profit share on one programme. Novo Nordisk will make an equity investment in ElevateBio, Li...
May 29, 2023 | News
Most Read
Bio Jobs
News